Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2018 - IJCMAS--ICV 2018: 95.39 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020]For more details click here

Login as a Reviewer

Indexed in



National Academy of Agricultural Sciences (NAAS)
NAAS Score: *5.38 (2019)
[Effective from January 1, 2019]
For more details click here

ICV 2018: 95.39
Index Copernicus ICI Journals Master List 2017 - IJCMAS--ICV 2018: 95.39
For more details click here

See Guidelines to Authors
Current Issues

Original Research Articles

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com / submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38

Int.J.Curr.Microbiol.App.Sci.2020.9(4): 3058-3071
DOI: https://doi.org/10.20546/ijcmas.2020.904.357


Immunotherapy: A Novel Approach to Fight Cancer
Nidhi Rawat1*, Fateh Singh2, Savita Bisen3 and Chandrahas Sannat1
1Department of Veterinary Microbiology, College of Veterinary Science and A.H.,
Anjora, Durg, Chhattisgarh, India
2National Institute of High Security Animal Disease Laboratory Bhopal,
 3Department of Veterinary Parasitology, College of Veterinary Science and A.H., Anjora, Durg, Chhattisgarh, India
 
*Corresponding author
Abstract:

Cancer immunotherapy is a type of therapy that uses the body's immune system to prevent, control, and eliminate cancers. The cancer cells on their surface often express the tumor antigens, which are targeted by the immune response components. The past decade has witnessed immunotherapy as an appealing and attractive strategy that established a strong pillar to fight various types of malignancies (Subramaniam et al., 2016). The therapeutic and prophylactic approaches of cancer immunotherapies have been tried against different types of cancers both in human and Veterinary medicine. Beginning with the preventive vaccine for cervical and liver cancer to the first therapy of metastatic melanoma, immunotherapy has already led to major treatment breakthroughs for a number of cancers throughout the world. Currently, the cancer immunotherapy has also become popular in India. Recent success of cancer immunotherapy including monoclonal antibodies, cancer vaccines, adoptive cancer therapy and immune checkpoint inhibitors has revolutionized traditional cancer treatment (Zhang and Chen, 2018). Incorporation of novel immunotherapeutic approaches has the potential to not only improve survival of cancer patients, but also reduce reliance on genotoxic high-dose chemoradiation (Sambi et al., 2019). However, there are many challenges in the way of cancer immunotherapy that will enable to select the rational strategies for overcoming barriers to effective antitumor responses (Dougan et al., 2019). Immunotherapy of cancer is a rapidly evolving field and despite the several obstacles, its current advanced approach has been proved as a potent defensive weapon because of which the deadly diseases like cancers are possible to cure, though not in all, but in many patients.


Keywords: Body's immune system, Therapeutic and prophylactic approach
Download this article as Download

How to cite this article:

Nidhi Rawat, Fateh Singh, Savita Bisen and Chandrahas Sannat. 2020. Immunotherapy: A Novel Approach to Fight Cancer.Int.J.Curr.Microbiol.App.Sci. 9(4): 3058-3071. doi: https://doi.org/10.20546/ijcmas.2020.904.357